SCHEMBL529595

SCHEMBL529595

CCCCc1cnc2ccc(-c3cc(F)c(O)c(Cl)c3)cc2c1Nc1ccc(N2CCNCC2)nc1

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MELK Q14680 20/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12505179 0.89 MELK (0.78) MELK
SCHEMBL531091 0.86 MELK (1.00) MELK
SCHEMBL530441 0.85 MELK (0.68) MELK
SCHEMBL17434976 0.84 MELK (0.77) MELK
SCHEMBL10282112 0.84 MELK (0.89) MELK
SCHEMBL15191016 0.84 MELK (1.00) MELK
SCHEMBL12505072 0.83 MELK (0.78) MELK
SCHEMBL529395 0.83 MELK (0.78) MELK
SCHEMBL530347 0.81 MELK (1.00) MELK
SCHEMBL529485 0.81 MELK (0.78) MELK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2597955-A1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME OncoTherapy Science, Inc. (JP) 2013-06-05 EP disclosed
WO-2012016082-A1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE, INC. (JP) 2012-02-02 WO disclosed